TrialHuman vaccines & immunotherapeutics2023

Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind trial.

Pio López et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.